Resveratrol inhibits epithelial-mesenchymal transition in hepatocellular carcinoma
Last updated: 23 Dec 2024
10.21608/jabps.2023.233421.1201
Hepatocellular carcinoma, epithelial-mesenchymal transition, Resveratrol, Akt/GSK3β/Snail pathway
Asmaa
Bayoumi
Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.
asmaa_bayoumi@mu.edu.eg
0000-0001-6757
Esraa
Khalifa
Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia 61519, Egypt
esramontaser88@gmail.com
Mohamed
Sayed-Ahmed
M.
Pharmacology and Experimental Oncology Unit, National Cancer Institute, Cairo University, Cairo 11796, Egypt.
sayed.ahmed@nci.cu.edu.eg
0000-0002-2179-8002
Marwa
Sharaky
Pharmacology and Experimental Oncology Unit, National Cancer Institute, Cairo University, Cairo 11796, Egypt.
marwa.sharaky@nci.cu.edu.eg
0000-0002-7894-3514
Maiiada
Nazmy
H.
Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.
maiiada_nazmy@mu.edu.eg
Minia
7
1
45148
2024-01-01
2023-09-06
2024-01-01
37
40
2535-1869
2535-2040
https://jabps.journals.ekb.eg/article_331627.html
https://jabps.journals.ekb.eg/service?article_code=331627
4
Review Articles
523
Journal
Journal of advanced Biomedical and Pharmaceutical Sciences
https://jabps.journals.ekb.eg/
Resveratrol inhibits epithelial-mesenchymal transition in hepatocellular carcinoma
Details
Type
Article
Created At
23 Dec 2024